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Abstract 
 
Hippocampal volumes are smaller in psychiatric disorder patients and lower levels of 
hippocampal neurogenesis are the hypothesized cause. Understanding which 
molecular processes regulate hippocampal progenitor differentiation might aid in the 
identification of novel drug targets that can promote larger hippocampal volumes. 
Here we use a unique human cell line to assay genome-wide expression changes when 
hippocampal progenitor cells differentiate. RNA was extracted from proliferating 
cells versus differentiated neural cells and applied to Illumina Human HT-12 v4 
Expression BeadChips. Linear regressions were used to determine the effect of 
differentiation on probe expression and we assessed enrichment for gene ontology 
(GO) terms. Genetic pathway analysis (MAGMA) was used to evaluate the 
relationship between hippocampal progenitor cell differentiation and adult 
hippocampal volume, using results from the imaging genomics consortium, 
ENIGMA. Downregulated transcripts were enriched for mitotic processes and 
upregulated transcripts were enriched for cell differentiation. Upregulated 
(differentiation) transcripts specifically, were also predictive of adult hippocampal 
volume; with Early growth response protein 2 identified as a hub transcription factor 
within the top GO term, and a potential drug target. Our results suggest that genes 
governing differentiation, rather than mitosis, have an impact on adult hippocampal 
volume and that these genes represent important drug targets. 
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Introduction 
 
The specialisation of pluripotent stem cells into neurons, commonly referred to as 
“neurogenesis”, occurs across all brain regions during foetal development [1]. 
Different niches of neural stem cells give rise to specialised neurons, glial cells and 
oligodendrocytes which inhabit specific brain regions [2]. Neurogenesis is affected by 
genetic, environmental, hormonal and epigenetic factors [3–5], and these likely 
moderate or trigger a series of molecular changes, resulting in the termination of a 
neural stem cell’s proliferation and the initiation of cell differentiation.  
 
The hippocampus is a brain structure important in learning, memory and mood, and 
interestingly continues to exhibit neurogenesis throughout an individual’s lifetime [6-
10]. Smaller hippocampal volumes have been linked to a variety of psychiatric 
disease states including post-traumatic stress disorder and major depressive disorder 
[11-13]. There are many cellular changes that could contribute to volume loss, 
including loss of dendritic length or spines, decreased glial size or number [14], yet a 
recent rodent study demonstrated that inhibition of hippocampal neurogenesis leads to 
hippocampal volume reduction [15].  Therefore, a greater understanding of what 
molecular processes regulate hippocampal neurogenesis may prove useful in 
understanding the development of this brain structure, its involvement in psychiatric 
disease, and in the development of pharmacotherapies which aim to target and reverse 
smaller hippocampal volumes. 
 
Previous work in non-human animal in vivo and in vitro systems have revealed 
substantial gene expression changes associated with neuronal differentiation, with 
Notch [16], Wnt [17-19] and brain derived neurotrophic factor (BDNF) [20-21] 
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signalling pathways hypothesized to be key regulators. However, regional 
specialisation in the brain is associated with specific and developmentally-sensitive 
changes to gene expression profiles [22]. Thus, it’s unclear whether the pathways 
previously implicated for neuronal differentiation are also important in regulating 
early hippocampal neural stem cell differentiation. Furthermore, it’s unclear what 
other transcriptional mechanisms might be important in regulating neural stem cell 
differentiation in the hippocampus in humans, in a hypothesis-free manner.  
 
Here, we investigated genome-wide expression changes occurring when proliferating 
human hippocampal progenitor cells differentiate over a 7-day period. We further 
created a “neural progenitor differentiation gene set”, and determined which 
biological processes are downregulated and upregulated in response to neural 
progenitor differentiation. We subsequently used gene co-expression analysis to 
understand which hub genes are important in driving neural progenitor differentiation, 
and we performed genetic pathway analysis to test whether genes within our neural 
progenitor differentiation gene set predicted adult hippocampal volume in the 
ENIGMA neuroimaging genetics dataset [23]. The ultimate aim was to identify 
druggable genes and/or gene networks capable of promoting neural progenitor 
differentiation and larger hippocampal volumes. 
 
Methods 
 
The Hippocampal Progenitor Cell Line 
The multipotent, human hippocampal progenitor cell line HPC0A07/03C (provided 
by ReNeuron, Surrey, UK) was used for all experiments, as described previously [24-
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26]. ReNeuron’s HPC0A07/03C cells were obtained from a 12-week old foetus (with 
a typical karyotype) and immortalised with c-mycER technology. In the presence of 
growth factors (FGF2 and EGF) and 4-Hydroxy-Tamoxifen (4-OHT), progenitors 
cells will proliferate and remain undifferentiated. Removal of these growth factors 
induces differentiation of cells, on average, into 52% of TuJ1-positive cells (of which 
35% are doublecortin-positive neuroblasts, 25% were MAP2-positive mature neurons, 
and 8% labelled positive for both, doublecortin and MAP2), 27% S100ß-positive 
astrocytes, 2% of O1-positive oligodendrocytes and 19% of GFAP-positive immature 
progenitor cells [24]. Cells were grown in Dulbecco’s Modified Eagle’s Media/F12 
(DMEM:F12, Invitrogen, Paisley, UK) supplemented with 0.03% human albumin 
(Baxter Healthcare, Compton, UK), 100 µg/ml human apo-transferrin (Sigma, St-
Louis, MO, USA), 16.2 µg/ml human putrescine DiHCl (Sigma), 5 µg/ml human 
insulin (Sigma), 60ng/ml progesterone (Sigma), 2 mM L-glutamine (Sigma) and 40 
ng/ml sodium selenite (Sigma). To maintain proliferation, 10 ng/ml human bFGF 
(Pepro Tech EC Ltd, London, UK), 20 ng/ml human EGF (Pepro Tech EC Ltd) and 
100 nM 4-OHT (Sigma) were added to proliferating media, and removed in 
differentiating media. All cells were grown at 37°C, 5% CO2, and in a humidified 
atmosphere.  
 
Cells used in this study and summary of cell protocol 
Data utilised here was collected as part of a set of 24 experiments, which assayed the 
effects of two antidepressant drugs on both proliferating and differentiating human 
hippocampal progenitor cell populations (25-26; S.1, Supplementary Information). 
Each experiment consisted of a control, low, medium and high drug dose. In the 
context of all adequately detected (unfiltered) probes on the microarray, neither drug 
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had significant effects on expression of individual genes [25-26]. The inclusion of 
untreated control conditions allowed us to regress out any minor effects of drug and 
drug dose within our conservative statistical models, in order to accurately compare 
proliferating versus differentiating cell gene expression profiles (see below). A 
summary of the protocol used throughout all experiments is summarised in Figure 1. 
 
<<< Figure 1>>> 
Figure 1: A summary of the protocol used for the proliferation and differentiation of 
human hippocampal progenitor cells. 
 
Protocol for Proliferating Cells 
Cells were seeded for 24 hours on laminin-coated 6 well plates (Nunclon, Roskilde, 
Denmark) in proliferating media. After seeding, media was changed and cells were 
incubated with proliferating media for a further 48 hours. Media was then aspirated 
and 1 ml of Trireagent (Sigma, St-Louis, MO, U.S.) was added for later RNA 
isolation. In total there were 48 independent proliferating cell populations grown in 
separate wells, which were obtained from six different passages.  
 
Protocol for Differentiating Cells 
The differentiation protocol incorporated the same procedures as described in the 
proliferation protocol. However, at the end of the 48-hour proliferating conditions, 
media was aspirated and replaced with differentiating media (lacking EGF, bFGF, 4-
OHT) twice over one hour to ensure thorough removal of growth factors. The cells 
were then grown in differentiating media for 7 days and differentiated into a 
glial/neuronal mixed culture containing a majority of neurons as shown previously 
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[24], confirmed here using immunocytoochemistry for S100β-positive astrocytes, 
doublecortin-positive neuroblasts, MAP2-positive and Prox1-positive neurons 
(Supplementary Information, S.2), where Prox1 has been shown to be a marker for 
dentate gyrus neurons [27]. Subsequently, cells underwent RNA collection as above. 
In total there were 48 independent differentiating cell populations grown in separate 
wells, which were obtained from seven different passages. The majority of 
proliferating and differentiating cells were obtained from the same passage numbers. 
 
Whole Genome Transcriptomics 
RNA from cell experiments was isolated using Trireagent (Sigma) following the 
standard protocol, with an additional ethanol precipitation step to increase RNA 
purity. All samples had 260/280 ratios of between 1.9 and 2.1 as tested using the 
Nanodrop D1000 (Thermoscientific, Wilmington, DE). All RNA samples had RNA 
integrity numbers (RINs) of greater than 9, as assessed using the Agilent Bioanalyzer 
2100 (Agilent Technologies, California, U.S.). 300 ng of RNA from each sample was 
processed on Illumina Human HT-12 v4 Expression BeadChip (Illumina Inc., 
California, U.S.) according to manufacturer’s protocol. Initial quality control 
assessment was performed in Genome Studio (Illumina), where outliers were 
identified using a scatterplot of average signal intensities. One sample was revealed as 
an outlier, and this was confirmed using hierarchical clustering. This sample was 
subsequently removed from downstream analysis. The Lumi (Bioconductor) package 
in R (http://www.R-project.org) was used for quality control, quantile-normalization, 
log-transformation and gene annotation [28]. Genes were then filtered based on 
detection values generated by Genome Studio. Expression probes had to reach the 
detection p-value threshold <0.01 in at least one sample, and if not, they were 
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excluded. Microarray data generated from this experiment has been made publically 
available on the Gene Expression Omnibus (GEO; accession number GSE95791). 
 
Quantitative Polymerase Chain Reaction (qPCR) Validation 
Complementary DNA (cDNA) was synthesized from 500 ng of RNA and utilised for 
qPCR validation, as part of a three-step process. In the first step genomic DNA 
(gDNA) was removed using the Precision DNase kit (Primer Design, Southampton, 
UK), following the standard manufacturer protocol. In the second step we converted 
RNA to cDNA using the Reverse Transcription premix kit (Primer Design), following 
the standard manufacturer protocol. Finally, we performed quantitative PCR reactions 
in 384-well plates. All samples under investigation were tested using three technical 
replicates, and three no-template controls were included for each gene being 
investigated. An eight point human leukocyte gDNA dilution series (0.47 ng, 0.94 ng, 
1.88 ng, 3.75 ng, 7.5 ng, 15 ng, 30 ng, 60 ng) was included for every gene, to create a 
standard curve, which was used to perform absolute quantification of each cDNA 
sample under investigation. Human primary cell derived BioBank T-cell cDNA 
(Primer Design) was also run on every plate as a positive control. 
 
Per reaction, the qPCR mix consisted of: 10 uL Precision PLUS SYBR green 
Mastermix (Primer Design), 10 uL RNase free water, 200 nM forward primer, 200 
nM reverse primer and 25 ng of cDNA. The thermocycling conditions consisted of 
three stages: Step 1: 2 minutes at 95°C; Step 2: 40 cycles at 95°C for 10 seconds 
followed by 60°C for 1 minute (data collection); Step 3: Melting curve. 
 
We selected the following genes for validation: brevican (BCAN), top upregulated 
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transcript; Transforming Growth Factor Beta Induced (TGFBI), top downregulated 
transcript; Doublecortin (DCX), a neuronal-specific marker; and Cell Division Cycle 
20 (CDC20), a cell cycle marker featured in our top downregulated gene network. For 
primer sequences, (S.3, Supplementary Information). 
 
For validation we used eight cDNA samples derived from proliferating cells and eight 
cDNA samples derived from differentiating cells. We selected Vimentin (VIM) as an 
endogenous reference gene, based on our microarray results demonstrating it was well 
expressed with a very low level of variation across all samples (C.V.<1%). This was 
especially necessary as traditional housekeeping genes showed high levels of 
variation (C.V.>1%), including β-actin (ACTB) and Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), which showed significant changes during differentiation 
(ACTB: log2(fold change) = -0.426917281, p = 1.91E-17; GAPDH: log2(fold 
change)= -0.408308201, p = 6.34E-20).  
 
Primers were designed by inputting the microarray probe sequence into BLAT 
(https://genome.ucsc.edu/cgi-bin/hgBlatoptio; build hg19) and identifying the exact 
genomic region it assays; selecting a ~400 BP region falling within a single exon 
covering this region; and inputting the genomic sequence into Primer3 
(http://primer3.ut.ee; product range of between 80-100 BP). Each primer was 
designed to generate a single amplicon, and to fall within a single exon, so that it 
would create the same product size for either gDNA or cDNA, allowing for the 
accurate use of a gDNA standard curve. For primer sequences see Supplementary 
Information. 
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Statistical Analysis 
(i) Determining Expression Changes During Hippocampal Neural Progenitor 
Differentiation: To assess the gene expression changes triggered when proliferating 
cells are left to differentiate, we performed a linear regression with probe expression 
as the dependent variable, proliferating/differentiating state as the independent 
variable, and array batch and biological replicate as factors. As we utilised some cell 
populations which had been drug treated, we also regressed out any minor influences 
of drug and drug dose.  
 
(ii) Gene Set Derivation & Gene Ontology Enrichment Of Upregulated And 
Downregulated Genes: To understand which biological mechanisms may be affected 
by cell differentiation we first identified a “neural progenitor differentiation gene set” 
consisting of probes which showed both a Bonferroni-significant change in 
expression and a log2(fold change) > ±0.5.  
 
To understand which biological mechanisms are being upregulated and 
downregulated within our neural progenitor differentiation gene set, we separately 
entered genes showing an increase in expression, and genes showing a decrease in 
expression, into the Gene Ontology enRIchment anaLysis and visuaLizAtion tool 
(GOrilla; http://cbl-gorilla.cs.technion.ac.il; [29]), and included all probes surviving 
background correction as our reference list. As part of GOrilla, we tested for Gene 
Ontology (GO) term enrichment for Biological Processes (GOTERM_BP_FAT), 
Cellular Components (GOTERM_CC_FAT) and Molecular Functions 
(GOTERM_MF_FAT), and we used the false discovery rate (q < 0.05) to correct for 
multiple testing. To visualise the top GO terms, we entered genes contributing to the 
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top upregulated and downregulated GO terms into GeneMania [30]. GeneMania uses 
previously published works to draw connections between genes within a user-defined 
list and establishes images of co-expression networks. 
 
(iii) Cell-Type-Associated Expression Changes During Differentiation: To 
determine which cell types were most likely driving changes to either upregulated or 
downregulated transcripts within our neural progenitor differentiation gene set, we 
linked immunocytochemistry data from the three main cell types in our multipotent 
culture (doublecortin-, MAP2- and S100β-positive cells) to our gene expression data 
(S.4, Supplementary Information). Similarly to whole blood experiments, we used the 
variance in cell type counts between samples to tease apart the contribution each cell 
type had to the overall transcriptomic profile [e.g. 31]. In this analysis we included all 
48 proliferating cell populations and assigned 0% marker expression for doublecortin, 
MAP2 and S100β, as cells are kept in an immature progenitor state and do not express 
these markers. We further included 17 differentiating cell populations for which we 
had percentage expression of these three markers. We subsequently performed the 
same linear model as in (i) in our downregulated/upregulated separately, but we also 
included percentage of cells expressing doublecortin, MAP2 and S100β in our model 
in order to tease apart cell-type-associated expression changes during differentiation. 
As our upregulated and downregulated gene sets had already been preselected from 
our main analysis (Bonferroni-significant with log2(fold change) > ±0.5), and because 
we had reduced power in this subset due to sample size, we applied a liberal 
significance threshold (p<0.05) when determining which cell type was most likely 
driving expression changes during differentiation. We further determined overlapping 
transcripts from our cell-type-associated results, with those transcripts overexpressed 
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in either neurons or astrocytes (relative to other central nervous system cells) from 
mouse brain, as described by Cahoy and colleagues [32] (S.5-S.8, Supplementary 
Information). 
 
(iv) Genetic Pathway Analysis: Genetic pathway analysis was used to determine the 
relationship between genes associated with neural progenitor differentiation (derived 
in (ii)) and adult hippocampal volume. As part of a sensitivity analysis, we 
investigated whether upregulated or downregulated genes within our neural 
progenitor differentiation gene set, showed stronger associative enrichment for single 
nucleotide polymorphisms (SNPs) nominally associated with hippocampal volume.  
 
To achieve this, we used the pathway analysis tool, MAGMA [33]. MAGMA tests for 
gene set enrichment by first generating a gene-wide statistic from the GWAS results 
files, adjusting for gene size, single nucleotide polymorphism (SNP) density and 
linkage disequilibrium effects [33]. It then performs a competitive test of gene set 
association [33]. The competitive test of association compares how well a gene set 
performs relative to other gene sets of similar size across the genome.  
 
We used a 35 kb 5’ and 10 kb 3’ window around genes to test if our neural progenitor 
differentiation gene set showed associative enrichment for SNPs nominally predicting 
hippocampal volume. GWAS summary statistics relating to hippocampal volume 
were made available via the ENIGMA Consortium. ENIGMA has performed the 
largest association studies to-date on brain volumes (meta-analyses), involving results 
from 50 separate studies [23]. In their hippocampal volume GWAS, they used data 
collected from 13,163 subjects (http://enigma.ini.usc.edu; see [23]); the results of 
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which we utilise here.  
 
(v) qPCR Validation: qPCR data was output from the ABI Prism SDS Software 
version 2.2 which generated cycle threshold (Ct) values for each sample. For a sample 
to be included in downstream data analysis, at least two of the Ct technical triplicates 
needed to achieve a standard deviation of less than 0.5. Remaining Ct values were 
then related to absolute quantities as part of a standard curve, creating Cq values. The 
mean Cq value for each target gene was divided by the mean Cq of the endogenous 
reference gene in order to generate relative expression. Independent t-tests were used 
to compare expression differences between proliferating and differentiating cells. 
 
Results 
 
Microarray analysis shows widespread transcriptional reprogramming during 
neural progenitor differentiation 
Our data revealed that 29,313 probes were adequately detected after background 
correction. Of these, 6,713 probes surpassed a Bonferroni p-value threshold of 
1.706E-06. 1,141 probes were both Bonferroni significant and demonstrated a 
log2(fold change) of greater than ±0.5; 652 of these transcripts were downregulated 
and 489 were upregulated. The distribution of p-values and log2(fold changes) are 
shown in Figure 2. For full results of the genes affected during differentiation, see 
S.10, Supplementary Information. For results on the relationship between cell-type 
and expression changes, see S.5-S.8, S.11, Supplementary Information.  
 
<<< Figure 2 >>> 
Figure 2: A volcano plot showing the distribution of log2(fold change) values and 
 14
associated –log(p) values for 29,313 probes, where we compared expression at each 
probe when cells were proliferating or undergoing neural progenitor differentiation. 
The data points shown in blue/red represent those probes included in our neural 
progenitor differentiation gene set, i.e. surpassing the Bonferroni-significance 
threshold (p<1.706E-06) with a log2(fold change) > ±0.5. 
 
The top ten genes showing a downregulation in expression, and upregulation in 
expression during neural progenitor differentiation are shown in Figure 3.  
 
<<< Figure 3>>> 
 
Figure 3: A bar chart showing the mean log2(fold change), y-axis, for the 10 
transcripts showing the largest downregulation in expression (blue) and the 10 
transcripts showing the largest upregulation in expression (red) when human 
hippocampal neural progenitor cells differentiate. All transcripts surpassed the 
Bonferroni correction for multiple testing. [TGFBI = Transforming Growth Factor 
Beta Induced; CNTNAP2 = Contactin-associated protein-like 2; ID3 = Inhibitor Of 
DNA Binding 3; S100A4 = S100 calcium-binding protein A4; DLGAP5 = Discs 
Large Homolog Associated Protein 5; UBE2T = Ubiquitin Conjugating Enzyme E2 T; 
FEN1 = Flap endonuclease 1; CDC20 = Cell-division cycle protein 20; ADORA1 = 
Adenosine A1 Receptor; S100A6 = S100 Calcium Binding Protein A6; LY6H = 
Lymphocyte antigen 6 complex, locus H; TAGLN = Transgelin; GPX3 = Glutathione 
peroxidase 3; VCAM1 = Vascular cell adhesion molecule 1; GPR117 = Wntless Wnt 
ligand secretion mediator; ANGPTL4 = Angiopoietin-like 4; CTGF = Connective 
tissue growth factor; CALB2 = Calbindin 2; BCAN = Brevican]. 
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qPCR Validates Microarray Findings 
All standard curves showed an R2 ≥ 0.99 between known DNA quantity and Ct 
values. None of the no-template controls showed amplification for any of our genes, 
and all positive cDNA controls showed amplification. Dissociation curves (melting 
curves) revealed a clear single peak for each gene, confirming amplification 
specificity. All samples passed quality control checks, and demonstrated S.D. < 0.5 
between technical replicates. Independent t-tests confirmed significant differences 
between proliferating and differentiating cell populations expressing TGFBI (t = 
9.038, d.f. = 7.338, p = 3.100E-05), BCAN (t = -4.390, d.f. =7.049, p = 3.140E-03), 
DCX (t = 4.044, d.f. = 14, p = 0.001) and CDC20 (t = 19.136, d.f. = 14, p = 1.95E-
11). 
<<< Figure 4 >>> 
Figure 4: This figure shows results from our qPCR validation experiments. The bar 
chart shows the mean relative expression of each gene in proliferating (blue; n=8) and 
differentiating (pink; n=8) human hippocampal progenitor cells. The error bars 
represent the standard error of the mean. All transcripts showed significant 
differences between proliferating and differentiating cell populations (p<0.005). Note: 
Expression of DCX and CDC20 have been multiplied by a factor of 4 to increase 
visibility. 
 
Gene Ontology analyses show a downregulation in genes controlling mitotic 
processes and an upregulation of genes controlling cellular differentiation 
Amongst the downregulated genes, GOrilla revealed a significant enrichment for 286 
biological processes, 54 molecular functions and 69 cellular components. Amongst 
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the upregulated genes, GOrilla revealed a significant enrichment for 56 biological 
processes, 2 molecular functions and 27 cellular components (S.12, Supplementary 
Information). The five most significant of each of these GO subtypes amongst the 
downregulated and upregulated gene sets are shown in Figures 5 and 6, alongside the 
most significant GO term visualised as a gene network. 
 
<<< Figure 5>>> 
Figure 5: Left: The five most significantly downregulated biological processes, 
molecular functions and cellular components (Gene Ontology terms, from left to 
right) after hippocampal neural progenitor cells differentiate for 7-days. Right: 
Transcripts within the GO term ‘Mitotic Cell Cycle Process’ (most significant term) 
visualised as a gene co-expression network. 
 
<<< Figure 6>>> 
Figure 6: Left: The five most significantly upregulated biological processes, 
molecular functions and cellular components (Gene Ontology terms, from left to 
right) after hippocampal progenitor cells differentiate for 7-days. Right: Transcripts 
within the GO term ‘Cell Differentiation’ (most significant term) visualised as a gene 
co-expression network. 
 
Genetic pathway analysis reveals that upregulated genes associated with 
differentiation predict adult hippocampal volume 
 
The MAGMA results revealed that our neural progenitor differentiation gene set was 
significantly enriched for genes predictive of hippocampal volume (p = 0.031). By 
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dissecting this gene list by upregulated/downregulated genes only, we found that it 
was specifically upregulated transcripts (i.e. those involved in differentiation) that 
were associated with hippocampal volume (p = 0.030), not downregulated transcripts 
(p = 0.478), Figure 7.  
<<< Figure 7>>> 
Figure 7: Bar charts showing results from MAGMA. Results from our competitive 
analyses investigating if our gene sets are enriched for SNPs predictive of adult 
hippocampal volume and whether they ‘outcompete’ gene sets of similar size. The 
initial association between our neural progenitor differentiation gene set and 
hippocampal volume was significant (p<0.05). Further consideration of  
downregulated (mitotic processes) and upregulated (differentiation) gene sets 
revealed that the association is being driven by upregulated genes governing 
differentiation, not the downregulated genes governing mitosis. Gene sets are shown 
on the x-axis, and the y-axis shows the -log10(p-value) output from MAGMA. The 
dashed line represents a p-value threshold of p=0.05. 
 
 
Discussion 
 
This study is the first to investigate the genome-wide expression changes which occur 
during human hippocampal progenitor cell differentiation as part of a 7-day protocol, 
Figure 1. Our results revealed extensive gene expression changes associated with 
differentiation, Figure 2. Top expression changes included functionally relevant 
genes, such as Transforming Growth Factor, Beta-Induced (TGFBI), Figures 3-4, 
which codes for a protein that increases in response to TGFB [34]. TGFB has 
previously been identified as a negative regulator of adult hippocampal neurogenesis 
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[35], therefore its downregulation during progenitor differentiation is consistent with 
this finding. Likewise, Inhibitor Of DNA Binding 3 (ID3) expression has been found 
to inhibit neurogenesis, therefore a downregulation during differentiation [36], Figure 
3, may act to disinhibit this mechanism. In contrast, some transcripts show an 
upregulation in expression during neural progenitor differentiation, such as brevican 
(BCAN), Figure 3-4, and Connective Tissue Growth Factor (CTGF), Figure 3. BCAN 
is proteoglycan that is specifically expressed in the central nervous system and has 
previously been linked to neuronal differentiation [37], and CTGF has been identified 
as a factor involved in regulating neuron survival [38].  
 
On a gene network level we found a very strong downregulation of transcripts 
controlling mitosis, which corresponds to the slowing down of cellular proliferation in 
our model, Figure 5. Whereas, there was a simultaneous upregulation of genes 
governing cellular differentiation and development, corresponding to the generation 
of young neurons and astrocytes observed in this cell line, Figure 6. Unlike previous 
studies [16-21], we did not identify Notch, Wnt and BDNF signalling pathways, as 
the top regulatory pathways, as indicated by our GO terms (Figures 5 and 6). 
However, individual members of the Notch (NOTCH2, DLL1) and Wnt (WNT5b, 
DVL3) pathways were significantly affected by neuronal differentiation, and there 
was a significant upregulation of BDNF, but the fold changes associated with these 
were below our threshold for inclusion in our neural progenitor differentiation gene 
set (see S.10., Supplementary information). The partial lack of replication here may 
relate to the multipotent nature of the stem cell line or the fact we are primarily 
generating immature neurons, rather than mature ones. However, when accounting for 
multipotency using staining data, genes associated with either young or more mature 
 19
neurons still did not include members of these pathways, which may suggest that on a 
genome-wide scale, and/or in human cells, they may be of less relevance to the 
differentiation of hippocampal progenitor cells.  
 
By performing genetic pathway analysis, we determined a positive associative 
enrichment for genes predicting hippocampal volume within our hippocampal neural 
progenitor differentiation gene set. This suggests that we have identified a set of 
relevant genes affecting both neural progenitor differentiation and long-term 
hippocampal volume, and subsequently we may have honed in on important, novel 
drug targets for the treatment of neuropsychiatric conditions, where there is a smaller 
hippocampus [11-13]. Through dissecting our gene set by upregulated/downregulated 
transcripts only, we found that only genes important in differentiation (upregulated 
transcripts) predicted hippocampal volume, not those governing neural progenitor 
proliferation (downregulated transcripts), Figure 7.  
 
Hub genes within the top co-expression network in our upregulated gene set includes 
three notable transcription factors, Early growth response proteins 1 (EGR1) and 2 
(EGR2) and CCAAT/enhancer-binding protein delta (CEBPD; Figure 6); with all 
three genes implicated in both the differentiation of young doublecortin-positive 
neurons and astrocytes, based on our cell-type associated analyses (Supplementary 
information). Transcription factors, such as these ones, play a role in regulating the 
expression of many other genes, allowing for co-ordinated and timely changes to 
protein expression, required for growth, development and response to environmental 
stimuli [39]. Thus, the ones we identify here, probably play a pivotal role in 
coordinating progenitor differentiation.  
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EGR-1 is a transcription factor highly expressed in young doublecortin-positive cells, 
and it has been used as a marker of neuronal activity and circuit integration [40]. 
Enhanced hippocampal neurogenesis via calorie restriction has been associated with 
rises in EGR-1, and EGR-1 is vital for hippocampal dependent long-term memory in 
mice [41]. Research has shown that CEBPD is also a transcription factor important in 
hippocampal neurogenesis in mice [42]. CEPBP knockout mice show a reduction in 
the number of new-born cells in dentate gyrus of the hippocampus and a decreased 
number of cells differentiating into neurons [42]. Out of the three transcription 
factors, however, EGR-2, was the one with the greatest number of single nucleotide 
polymorphisms associated with hippocampal volume (most significant individual 
SNP was rs7913336, p = 0.00086; S.9., Supplementary Information), and is the gene 
which had the strongest change within our differentiation assay (log fold change = 
1.30, p = 6.23E-25). This arguably suggests that EGR-2 may be the transcription 
factor of greatest importance in both coordinating neural progenitor differentiation 
and subsequently long-term hippocampal volume. EGR-2 has also been found to be 
upregulated in mouse neurons relative to other central nervous system cell types [32]; 
S.5., Supplementary information. Previous research has also implicated EGR-2 in 
both differentiation and the myelination of nerve cells in mice [43], and mutations 
within the EGR-2 gene have been associated with peripheral neuropathies, including 
Charcot-Marie-Tooth type 1, Dejerine-Sottas syndrome and congenital 
hypomyelinating neuropathy [44]. Further work is now needed to understand if 
modulating EGR-2 levels has a role in affecting hippocampal volume via neurogenic 
mechanisms. 
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Although our study provides potentially important insights into the cellular and 
molecular regulation of long-term hippocampal volume, there are several limitations 
to consider. First, we utilised a conditionally immortalised cell line from a single 
human donor. Ideally, future studies should validate findings reported here, in cells 
which are not artificially affected by immortalisation and are collected from several 
independent donors. Secondly, even though the ENIGMA GWAS on hippocampal 
volume involves the largest cohort to-date, it may still be underpowered, which may 
dilute the genetic signal and weaken the accuracy of our genetic pathway results. 
 
In conclusion, our study is the first to describe genome-wide expression changes 
during human hippocampal progenitor differentiation. We provide the first empirical 
evidence showing a biological relationship between early hippocampal neurogenesis 
and long-term adult hippocampal volume in humans. These results suggest that inter-
individual variation in genes triggering the differentiation of progenitor cells, evoke 
long lasting differences to hippocampal volume. Whereas, inter-individual variation 
in genes governing progenitor proliferation may be less important in affecting long-
term hippocampal volume in adults. Our results differ from previous studies as we did 
not identify Wnt, Notch or BDNF as the most important mediators of progenitor 
differentiation, rather our work implicates the importance of the transcription factors 
EGR1, CEBPD and particularly EGR2. We believe the data generated within our 
study provides a resource for others to test for further biological associations, and our 
data also suggests novel targets for drugs which aim to increase hippocampal volume 
in the treatment of psychiatric disease. 
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